| 1 |
poly(ADP-ribose) polymerase-1
(1015 times)
|
Biochemistry
(249 times)
|
AIF (61 times)
PAR (59 times)
ROS (56 times)
|
2000 Characterization of sPARP-1. An alternative product of PARP-1 gene with poly(ADP-ribose) polymerase activity independent of DNA strand breaks.
|
| 2 |
poly(adenosine diphosphate-ribose) polymerase-1
(16 times)
|
Medicine
(2 times)
|
AMPK (2 times)
PAR (2 times)
3-AB (1 time)
|
2003 Problems associated with determining protein concentration: a comparison of techniques for protein estimations.
|
| 3 |
PAR polymerase-1
(5 times)
|
Biochemistry
(3 times)
|
PAR (5 times)
PARG (2 times)
EC-PAR (1 time)
|
2009 Interaction of Sindbis virus non-structural protein 3 with poly(ADP-ribose) polymerase 1 in neuronal cells.
|
| 4 |
cleaved-poly(ADP-ribose) polymerase 1
(2 times)
|
Drug Therapy
(1 time)
|
AD (1 time)
Bcl-2 (1 time)
DM (1 time)
|
2012 NAD+ metabolism and NAD(+)-dependent enzymes: promising therapeutic targets for neurological diseases.
|
| 5 |
poly ADP (ADP: adenosine diphosphate)-ribose polymerase-1
(2 times)
|
Chemistry Techniques, Analytical
(1 time)
|
AAO (1 time)
HRP (1 time)
|
2018 Ultrasensitive electrochemical detection of poly (ADP-ribose) polymerase-1 via polyaniline deposition.
|
| 6 |
Poly(ADP)-ribosyltransferase 1
(2 times)
|
Molecular Biology
(1 time)
|
AK (1 time)
|
2008 ADP-ribosylation of actin by the Clostridium botulinum C2 toxin in mammalian cells results in delayed caspase-dependent apoptotic cell death.
|
| 7 |
Poly(ADP-ribose)-1
(2 times)
|
Neurology
(1 time)
|
AIF (1 time)
MNNG (1 time)
SIRT1 (1 time)
|
2010 NAD+ depletion is necessary and sufficient for poly(ADP-ribose) polymerase-1-mediated neuronal death.
|
| 8 |
poly(ADPR) polymerase-1
(2 times)
|
Biochemistry
(1 time)
|
AD (1 time)
cDDP (1 time)
MARs (1 time)
|
2005 Co-localization of poly(ADPR)polymerase 1 (PARP-1) poly(ADPR)polymerase 2 (PARP-2) and related proteins in rat testis nuclear matrix defined by chemical cross-linking.
|
| 9 |
poly-ADP-ribose 1
(2 times)
|
Allergy and Immunology
(1 time)
|
Bax (1 time)
caspase 8 (1 time)
CHX (1 time)
|
2008 Bax shuttling after neonatal hypoxia-ischemia: hyperoxia effects.
|
| 10 |
P-labelled automodified pADPr polymerase-1
(1 time)
|
Biochemistry
(1 time)
|
hnRNPs (1 time)
pADPr (1 time)
|
2003 A proteomic approach to the identification of heterogeneous nuclear ribonucleoproteins as a new family of poly(ADP-ribose)-binding proteins.
|
| 11 |
PAR-1 agonist peptide
(1 time)
|
Chemistry
(1 time)
|
PARP-2 (1 time)
PARs (1 time)
|
2002 Presence of functionally active protease-activated receptors 1 and 2 in myenteric glia.
|
| 12 |
PARP-2 in vitro, the most active being 5-amino-3-methylisoquinolin-1-one
(1 time)
|
Biochemistry
(1 time)
|
5-AIQ (1 time)
|
2013 One-pot tandem Hurtley-retro-Claisen-cyclisation reactions in the synthesis of 3-substituted analogues of 5-aminoisoquinolin-1-one (5-AIQ), a water-soluble inhibitor of PARPs.
|
| 13 |
PARP-DBD
(1 time)
|
Biochemistry
(1 time)
|
PARP (1 time)
PI 3-kinase (1 time)
siRNA (1 time)
|
2005 Pivotal role of Akt activation in mitochondrial protection and cell survival by poly(ADP-ribose)polymerase-1 inhibition in oxidative stress.
|
| 14 |
poly(ADP-ribose)-1 gene
(1 time)
|
Drug Therapy
(1 time)
|
WT (1 time)
|
2003 Activation of p53 protein in normal and in tumor cells by a novel anticancer agent CHS 828.
|
| 15 |
poly(ADP-ribose)polymerase-1 activity
(1 time)
|
Cell Biology
(1 time)
|
PHE (1 time)
|
2011 Effects of 6(5H)-phenanthridinone, an inhibitor of poly(ADP-ribose)polymerase-1 activity (PARP-1), on locomotor networks of the rat isolated spinal cord.
|
| 16 |
poly-(ADP-ribose) transferase/polymerase-1
(1 time)
|
Genetics, Medical
(1 time)
|
PD (1 time)
|
2005 Regulation of alpha-synuclein expression by poly (ADP ribose) polymerase-1 (PARP-1) binding to the NACP-Rep1 polymorphic site upstream of the SNCA gene.
|
| 17 |
polymerase type 1
(1 time)
|
Aging
(1 time)
|
---
|
2018 PARP-1 Inhibition Rescues Short Lifespan in Hyperglycemic C. Elegans And Improves GLP-1 Secretion in Human Cells.
|
A Search Service for Abbreviation / Long Form